the incorporation of 3 H-thymidine by 50% (IC50) at a dose of 2.6 X 10~4 M in L 1210 and at a dose of 6 X 10~4 M in P 388 murine leukemias. On the basis of cell fractionation studies, compound 2 was found to bind about equally to the cell nuclei, microsomes, and mitochondria. ESR experiments indicate different degrees of immobilization of the label in various fractions. The efficiency of binding of 2 to cells appears to be at least 6 %.
Introduction
Recently, we reported [1] concerning the antitumor activity of two spin labeled analogs of the clinically used Thio-TEPA (1). Thus, SL-O-TT (2) and SL-NH-TT (3) [2] were evaluated, in accordance with the protocol [3] , in vivo against lymphocytic P 388 murine leukemia. It was found that 3>2>1. Further, it was found that compound 2 interfered with the incorporation of 3 H-thymidine into P 388 cells. On the basis of the electron spin resonance spectroscopy (ESR) using L 1210 cells incubated with SL-O-TT (2), it was concluded that 2 is bound to cells in culture in such a way as to restrict the motion of the nitroxyl label. Now we wish to report further details concerning the experiments on i) the inhibition of replication of lymphocytic P 388 and lymphoid L 1210 murine leukemia cells treated with 2 using 3 H-thymidine incorporation assay and ii) the binding of 2 to cells using cell fractionation studies in conjunction with ESR spectroscopy and colorimetric analysis.
Materials and Methods
Spin labeled Thio-TEPA (2) was synthesized as previously described [4] . In order to determine the extent of alkylating capacity still present in each cell fraction containing bound 2, colorimetric analyses were performed by the method of Friedman and Boger [5] . Because of poor solubility of SL-O-TT (2) in water, all experiments were performed using solutions of 2 containing 0.1-1% ethanol.
The effect of ethanol on these experiments was found to be insignificant. Lymphocytic P 388 murine leukemia cells were maintained in vitro by serial culture in a 1:1 mixture of RPMI 1630 and RPMI 1640 media (National Institutes of Health Media Unit, Bethesda, MD) containing 0.01 mM mercaptoethanol, 15% fetal calf serum (FCS, Flow Laboratories), and 50 I. U./ml penicillin, 50 //g/ml streptomycin, and 2 ^mol/ml L-glutamine (Flow Laboratories, Rockville, MD). Under these conditions, cells had a population doubling time of 14-18 h, and achieved a maximum density of 2-2.5 X 10 6 cells/ml. Lymphoid L 1210 murine leukemia cells w r ere maintained in vitro by serial culture in RPMI 1630 medium containing 15% FCS, penicillin, streptomycin, and L-glutamine as in the above medium. Under these conditions, cells had a population doubling time of 12-14 h, and achieved a maximum density of 1.5-2.0 X 10 6 cells/ml.
Incorporation of radioactive thymidine was performed as follows: after incubation of 10 6 cells/ml of L1210 or P 388 for 120 min with SL-O-TT (2), 0.1 ml of a medium containing 1 t<Ci of 3 Hthymidine (2.0 Ci/mmol, New England Nuclear, Boston, MA) w r as added to a 1 ml final volume of culture. After further incubation for 60 min with the radioactive nucleoside, the cells were assayed for the incorporation of tritium into the material which was precipitated with trichloroacetic acid as described by Felsted [6] .
ESR spectra were obtained with a Varian E-109 Century Series Spectrometer using a rectangular TE-104 dual cavity with a strong pitch standard in the reference cavity. Strong pitch at g = 2.0028 was used to evaluate experimental g-values. Since the signals obtained from the cell fractions were weak, a Nicolet model 1180 computer was used to obtain data by multiple scans. A sample of about 10 7 cells was suspended in 40 ml of RPMI 1630 containing 5 ml fetal calf serum, and incubated for 30 min. Then 20 ml of RPMI containing 8.37 mg of compound 2 were added to the cells to achieve a final concentration of 4 X IO -4 M in compound 2. The mixture was incubated for 2 h at 37 °C, 5% CO2, and 100% humidity. Following the incubation, two sets of experiments were performed, i) In the first set of experiments the aim was to establish the percent of total binding of 2 to cells. For this purpose, the cells were centrifuged, and the sediment and supernatant separated. The sediment was sonicated until at least 95% of cells were disrupted. The sonicated cells were treated with a 0.01-0.1 mM aqueous solution of ferricyanide in order to reoxidize any label which might have been reduced. The label present in the supernatant had not undergone extensive reduction. The sonicated cells and the supernatant fractions were then analyzed by ESR spectroscopy. After adjusting for relative instrumental gains, the ratio of the integrations was determined, ii) In the second set of experiments, the aim was to analyze the individual cell components. For this purpose, the cells were washed four times with a saline solution, resuspended in a swelling buffer, and homogenized until 95% of cells were disrupted. The cells were then fractionated by centrifugation. The nuclei were obtained by spinning the lysed cells at 4.2 Krpm, the mitochondria by spinning at 14.2 Krpm, and the microsomes by spinning at 50 Krpm. The supernatant of the last centrifugation was the soluble fraction (cytosol). The individual fractions were analyzed by ESR spectroscopy and the colorimetric assay [5] . 
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Fig. 2. Plot of the inhibition of the incorporation of 3 H-thymidine into P388 cells treated with SL-O-TT (2).
Results and Discussion
In Figures 1 and 2 are shown the plots of the inhibition of the incorporation of 3 H-thymidine into L 1210 and P 388 cells, respectively, treated with SL-O-TT (2) as a function of dose. Compound 2 interferes with the mechanism of replication of the tumor cells. In the case of L 1210 leukemia, a 50% inhibition of cell replication (IC50) is achieved at a dose of 2.6 x 10-4 M of 2, and in the case of P 388 g = 2.0028 MITOCHONDRIA leukemia, a 50% inhibition is achieved at the dose of 6 x 10 -4 M of 2.
In Figure 3 are shown the ESR spectra of fractions obtained after lysing of L 1210 cells treated with SL-O-TT (2). On the basis of the degree of distortions of the high field lines of spectra of the individual fractions, it can be concluded that 2 is covalently bound in a relatively unhindered environment in the case of microsomal fraction and bound or unbound in the cytosol fraction. In contrast, SL-O-TT (2) is somewhat immobilized in the mitochondrial and nuclear fractions, i.e., it is covalently bound in such a way as to restrict the motion of the label. Because of low concentration of the nitroxyl in these fractions, and consquenty, the weak ESR signals, it is difficult to quantitate the extent of binding of 2 to the individual fractions. On the basis of the colorimetric data, (Table I) , it can be assumed that 2 is distributed about equally throughout all cell components, including the nucleus, the site of the DNA. Some quantitation can be obtained with ESR on the total g = 2.0028 3 X 10-5 2 X 10- 5 3 X 10~5cell-drug binding by performing a double integration of the ESR signals derived from 2 bound to cells, and of the supernatant following a two hour incubation (see Methods). Washed cells were sonicated and treated with ferricyanide as described previously. After the adjustment for the relative instrumental gains, the ratio of integrations of these spectra was determined. On the basis of this ratio, it appears that the extent of incorporation of 2 into cells is approximately 6 % (Figure 4 ). Although this value is acceptable for the efficiency of binding of 2 to cells, the true extent of binding might, in fact, be significantly higher, since it was found [7] that in biological systems, the nitroxyl moiety is readily undergoing degradative reductions to give products which cannot be restored quantitatively to the original nitroxyl species by oxidative procedures. Surprisingly, the individual cell fragments containing the bound 2 still possess some alkylation ability even after sonication and fractionation into microsomes, mitochondria, nuclei, and cytosol. Thus, after incubation of the whole cells in a concentration of 4 x 10~4 M of 2, and, therefore, 8 X 10~4 M of aziridine moiety, there is still found, on the basis of the colorimetric assay [5] , about 5 X IO -5 M of alkylating activity. In addition, the individual fractions of microsomes, mitochondria, and nuclei, have about equal levels of alkylating capacity, whereas cytosol has about one thenth that capacity (Table I) . It has been proposed [8, 9] that the crosslinking of DNA is the principle cause of cell cycle inhibitions, and for this reason, polyfunctional antineoplastic agents are more cytotoxic to tumors than mono functional analogs. The fact that approximately 0.6% of alkylating activity was still found in the cell fragements indicates that at least some of the compound 2 is bound to cells in such a way as to retain some of the alkylating moieties
In conclusion, it was shown that compound 2 interferes with the replication mechanism of tumor cells as evidenced by the inhibition of 3 H-thymidine uptake by P 388 and L 1210 leukemia cells treated with 2. The inhibition, probably involving the DNA replication, is the result of a covalent binding of 2, to an extent of at least 6 % with various cell components including the nucleus.
